Aufrufe: 92
1. Summary of the notification
EQT VIII Fund reported in its notification dated 27 February 2026, that on 26 February 2026, following a disposal of voting securities, its participation decreased and crossed downwards the lowest threshold of 3.00% in Azelis Group NV.
On 26 February 2026, EQT VIII Fund (taking into account the holding of its affiliates) no longer owned any Azelis shares with voting rights, representing 0.00% of the total number of shares issued by the company (243,921,719), versus 24,226,853 shares representing 9.93% in its previous notification dated 14 November 2025.
2. Content of the notification
Reason for the notification
Acquisition or disposal of voting securities or voting rights
Downward crossing of the lowest threshold
Notification by
A parent undertaking or a controlling person
Persons subject to the notification requirement
| Name | Address (for legal entities) |
| EQT VIII Collect SCSp | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg |
| EQT VIII SCSp | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg |
| EQT VIII Investments S. à r. l. | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg |
| Akita I S. à r. l. | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg |
Date on which the threshold is crossed
26 February 2026
Threshold that is crossed (in %)
3%
Denominator
243,921,719
Notified Details
| A) Voting rights | Previous notification | After the transaction | |||
|
| # of voting rights | # of voting rights | % of voting rights | ||
| Holders of voting rights |
| Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities |
| EQT VIII Collect SCSp | 0 | 0 | 0 | 0.00% | 0.00% |
| EQT VIII SCSp | 0 | 0 | 0 | 0.00% | 0.00% |
| EQT VIII Investments S. à r. l. | 0 | 0 | 0 | 0.00% | 0.00% |
| Akita I S. à r. l. | 24,226,853 | 0 | 0 | 0.00% | 0.00% |
| Subtotal | 24,226,853 | 0 | 0 | 0.00% | 0.00% |
|
| TOTAL | 0 | 0 | 0.00% | 0.00% |
| B) Equivalent financial instruments | After the transaction | |||||
| Holders of equivalent | Type of financial instrument | Expiration date | Exercise period or date | # of voting rights that may be acquired if the instrument is exercised | % of voting rights | Settlement |
|
|
|
|
|
|
|
|
|
| TOTAL |
| 0 | 0.00% |
| |
| TOTAL (A & B) |
|
| # of voting rights | % of voting rights |
| CALCULATE | 0 | 0.00% |
Chain of controlled undertakings through which the holding is effectively held, if applicable
Akita I S. à r. l. (in voluntary liquidation) is controlled by EQT VIII Investments S. à r. l. that is controlled by EQT VIII SCSp. EQT VIII SCSp is controlled by EQT VIII Collect SCSp. EQT VIII Collect SCSp is not controlled by any of its shareholders. EQT VIII Collect SCSp is managed by EQT Fund Management S.à r.l.
3. Further information
The full transparency notification as well as this press release can be consulted on the Azelis Group NV’s website.
··················· END ···················
About Azelis
Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry, present in 64 countries across the globe with over 4,100 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a comprehensive portfolio of complementary products to more than 65,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.1 billion (2025). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.
Across our extensive network of more than 70 application laboratories, our award-winning teams develop innovative and sustainable formulations and provide technical guidance throughout the product development process. We combine global market reach with a local footprint to offer reliable, integrated, and unique digital services to local customers and attractive business opportunities to principals. Recognised for our sustainability leadership, we are committed to responsible growth that positively impacts people, communities and the planet. Through the application of science and deep market expertise, we act as catalysts for innovation, enabling our customers to win and our principals to grow.
Innovation through formulation
View source version on businesswire.com: https://www.businesswire.com/news/home/20260302523131/en/
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
